An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
Clinical trial NCT05085964 · TERMINATED
Trial details
- NCT number
- NCT05085964
- Sponsor
- Laboratoires Thea
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2022-10-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.